Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy-Reference-Cited by-同舟云学术

Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy

Published:2017-10 Issue:20 Volume:25 Page:5692-5708
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

El Hilali Mostafa,Reux Bastien,Debiton Eric,Leal Fernand,Galmier Marie-Josephe,Vivier Magali^ORCID,Chezal Jean-Michel,Miot-Noirault Elisabeth,Coudert Pascal,Weber Valérie

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference48 articles.

1. Cancer targeted therapeutics: From molecules to drug delivery vehicles;Liu;J Controlled Release,2015

2. Coming-of-age of antibodies in cancer therapeutics;Ayyar;Trends Pharmacol Sci,2016

3. Principles in the design of ligand-targeted cancer therapeutics and imaging agents;Srinivasarao;Nat Rev Drug Discov,2015

4. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship;Leamon;Bioconjug Chem,2014

5. Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy;Guaragna;Bioconjug Chem,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug;Biomaterials;2024-09

2. In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment;International Journal of Molecular Sciences;2021-02-09

3. Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo;ACS Omega;2020-07-29